PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
4-1BB Receptor 20 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
4-Mercaptobenzoic Acid 70 Drug Disease Hepatitis 163,842 2 0.00 -0.99 0.03 0.56
4-Mercaptobenzoic Acid 70 Drug Disease Malaria 56,215 1 0.00 -0.99 0.01 0.56
4-Mercaptopyridine 96 Drug Disease Cancer 1,053,491 1 0.00 -0.99 0.01 0.50
4-Mercaptopyridine 96 Drug Disease Leukemia 162,805 2 0.00 -0.99 0.02 0.55
4-Mercaptopyridine 96 Drug Disease Glioblastoma 17,933 1 0.00 -0.99 0.01 0.59
464.1 19 Target Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
464.1 19 Target Disease Cholesterol 182,390 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Asthma 109,610 1 0.00 -0.97 0.05 0.57
464.1 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
5-Hydroxytryptamine 2a Receptor 67 Target Disease Mania 7,698 1 0.00 -0.99 0.01 0.61
5-Hydroxytryptamine 2a Receptor 67 Target Disease Psoriasis 26,882 1 0.00 -0.99 0.01 0.58
5-Hydroxytryptamine 2a Receptor 67 Target Disease Autism 20,962 1 0.00 -0.99 0.01 0.59
5-Hydroxytryptamine 2a Receptor 67 Target Disease Pain 409,851 2 0.00 -0.98 0.03 0.54
5-Hydroxytryptamine 2a Receptor 67 Target Disease Seizures 66,465 1 0.00 -0.99 0.01 0.56
5-Hydroxytryptamine 2a Receptor 67 Target Disease Inflammation 252,734 1 0.00 -0.99 0.01 0.53
5-Hydroxytryptamine 2b Receptor 18 Target Disease Central Nervous System Diseases 715 1 0.01 -0.97 0.06 0.70
5-Hydroxytryptamine 2b Receptor 18 Target Disease Obesity 138,233 1 0.00 -0.97 0.06 0.57
5-Hydroxytryptamine 2b Receptor 18 Target Disease Migraine 24,200 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.06 0.59
5-Hydroxytryptamine 2b Receptor 18 Target Disease Heart Disease 118,291 5 0.00 -0.85 0.28 0.61
744.1 22 Target Disease Carcinoma 433,099 1 0.00 -0.98 0.05 0.54
744.1 22 Target Disease Acute Promyelocytic Leukemia 4,780 1 0.00 -0.98 0.05 0.64
744.1 22 Target Disease Chronic Obstructive Pulmonary Disease 27,780 1 0.00 -0.98 0.05 0.60
744.1 22 Target Disease Stroke 146,992 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Hepatitis 163,842 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Cardiac Arrest 20,700 2 0.00 -0.95 0.09 0.62
744.1 22 Target Disease Dyslipidemia 15,225 1 0.00 -0.98 0.05 0.61
744.1 22 Target Disease Leukemia 162,805 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Inflammation 252,734 2 0.00 -0.95 0.09 0.57
744.1 22 Target Disease Liver Disease 49,817 1 0.00 -0.98 0.05 0.59
744.1 22 Target Disease Heart Disease 118,291 2 0.00 -0.95 0.09 0.58
A1AT 329 Target Disease Renal Failure 73,993 1 0.00 -1.00 0.00 0.53
A1AT 329 Target Disease Arthritis 128,324 5 0.00 -0.99 0.02 0.55
A1AT 329 Target Disease Anemia 81,663 1 0.00 -1.00 0.00 0.53
A1AT 329 Target Disease Respiratory Tract Infections 9,721 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Acute Coronary Syndromes 9,133 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Rheumatoid Arthritis 78,952 3 0.00 -1.00 0.01 0.55
A1AT 329 Target Disease Cholesterol 182,390 2 0.00 -1.00 0.01 0.53
A1AT 329 Target Disease Hepatitis 163,842 19 0.00 -0.97 0.06 0.58
A1AT 329 Target Disease Menopause 19,680 1 0.00 -1.00 0.00 0.56
A1AT 329 Target Disease Ileus 9,091 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Rare Diseases 2,212 1 0.00 -1.00 0.00 0.62
A1AT 329 Target Disease Psoriasis 26,882 2 0.00 -1.00 0.01 0.57
A1AT 329 Target Disease Pain 409,851 4 0.00 -0.99 0.01 0.52
A1AT 329 Target Disease Leukemia 162,805 2 0.00 -1.00 0.01 0.53
A1AT 329 Target Disease Breast Cancer 173,695 3 0.00 -1.00 0.01 0.54